Search research articles
Contact Us
Filters
Showing results (851-860 of 909) with videos related to
Page
of 91
Sort By:
British Journal of Clinical Pharmacology
|
November 16, 2020
Safety, pharmacokinetics and pharmacodynamics of SBT-020 in patients with early stage Huntington's disease, a 2-part study
Marcus P J van Diemen, Ellen P Hart, Anthony Abbruscato, et al.
Molecular Cancer Therapeutics
|
December 8, 2011
Molecular and cellular pharmacology of the hypoxia-activated prodrug TH-302
Fanying Meng, James W Evans, Deepthi Bhupathi, et al.
British Journal of Clinical Pharmacology
|
April 22, 2021
Validation of a perioperative population factor VIII pharmacokinetic model with a large cohort of pediatric hemophilia a patients
Tim Preijers, Ri Liesner, Hendrika C A M Hazendonk, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
May 9, 2012
Evaluation of longitudinal 12 and 24 month cognitive outcomes in premanifest and early Huntington's disease
Julie C Stout, Rebecca Jones, Izelle Labuschagne, et al.
Blood
|
March 8, 2012
Hypoxia promotes dissemination of multiple myeloma through acquisition of epithelial to mesenchymal transition-like features
Abdel Kareem Azab, Jinsong Hu, Phong Quang, et al.
The European Respiratory Journal
|
March 12, 2026
Safety and efficacy of namilumab for the treatment of chronic pulmonary sarcoidosis (RESOLVE-Lung): A randomized, double-blinded, multicenter, Phase 2 study
Bernt Van Den Blink, Surinder S Birring, Nesrin Mogulkoc, et al.
Human Molecular Genetics
|
September 20, 2015
Fragile X protein mitigates TDP-43 toxicity by remodeling RNA granules and restoring translation
Alyssa N Coyne, Shizuka B Yamada, Bhavani Bagevalu Siddegowda, et al.
Molecular Pharmacology
|
April 14, 2019
Functional CRISPR and shRNA Screens Identify Involvement of Mitochondrial Electron Transport in the Activation of Evofosfamide
Francis W Hunter, Jules B L Devaux, Fanying Meng, et al.
Biorxiv : the Preprint Server for Biology
|
March 27, 2026
Female iPSC X-chromosome inactivation (XCI) erosion and its transcriptomic effects during CRISPR gene editing and neural differentiation
Christina Thapa, Emily K Oh, David Sirkin, et al.
Stem Cell Reports
|
September 13, 2024
Scaled and efficient derivation of loss-of-function alleles in risk genes for neurodevelopmental and psychiatric disorders in human iPSCs
Hanwen Zhang, Ada McCarroll, Lilia Peyton, et al.
Page
of 91
Search research articles
Search
Showing results (851-860 of 909) with videos related to
Sort By:
Page
of 91
British Journal of Clinical Pharmacology
|
November 16, 2020
Safety, pharmacokinetics and pharmacodynamics of SBT-020 in patients with early stage Huntington's disease, a 2-part study
Marcus P J van Diemen, Ellen P Hart, Anthony Abbruscato, et al.
Molecular Cancer Therapeutics
|
December 8, 2011
Molecular and cellular pharmacology of the hypoxia-activated prodrug TH-302
Fanying Meng, James W Evans, Deepthi Bhupathi, et al.
British Journal of Clinical Pharmacology
|
April 22, 2021
Validation of a perioperative population factor VIII pharmacokinetic model with a large cohort of pediatric hemophilia a patients
Tim Preijers, Ri Liesner, Hendrika C A M Hazendonk, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
May 9, 2012
Evaluation of longitudinal 12 and 24 month cognitive outcomes in premanifest and early Huntington's disease
Julie C Stout, Rebecca Jones, Izelle Labuschagne, et al.
Blood
|
March 8, 2012
Hypoxia promotes dissemination of multiple myeloma through acquisition of epithelial to mesenchymal transition-like features
Abdel Kareem Azab, Jinsong Hu, Phong Quang, et al.
The European Respiratory Journal
|
March 12, 2026
Safety and efficacy of namilumab for the treatment of chronic pulmonary sarcoidosis (RESOLVE-Lung): A randomized, double-blinded, multicenter, Phase 2 study
Bernt Van Den Blink, Surinder S Birring, Nesrin Mogulkoc, et al.
Human Molecular Genetics
|
September 20, 2015
Fragile X protein mitigates TDP-43 toxicity by remodeling RNA granules and restoring translation
Alyssa N Coyne, Shizuka B Yamada, Bhavani Bagevalu Siddegowda, et al.
Molecular Pharmacology
|
April 14, 2019
Functional CRISPR and shRNA Screens Identify Involvement of Mitochondrial Electron Transport in the Activation of Evofosfamide
Francis W Hunter, Jules B L Devaux, Fanying Meng, et al.
Biorxiv : the Preprint Server for Biology
|
March 27, 2026
Female iPSC X-chromosome inactivation (XCI) erosion and its transcriptomic effects during CRISPR gene editing and neural differentiation
Christina Thapa, Emily K Oh, David Sirkin, et al.
Stem Cell Reports
|
September 13, 2024
Scaled and efficient derivation of loss-of-function alleles in risk genes for neurodevelopmental and psychiatric disorders in human iPSCs
Hanwen Zhang, Ada McCarroll, Lilia Peyton, et al.
Page
of 91